Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM(@agingdoc1):GLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease Clinical trial of semaglutide drug is first to show improvement in liver scarring among patients with early cirrhosis https://t.co/JA9D5krQBT 🔬Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial

Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM

@agingdoc1

Longevity medicine best practices | healthspan | precision medicine | bio/acc | consulting @ Connect:

Joined May 2020

100 Following 53.8K Followers

Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM@agingdoc1

2026.10.17 02:14

GLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease Clinical trial of semaglutide drug is first to show improvement in liver scarring among patients with early cirrhosis 🔬Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial